Originally, Precedex was approved in Japan in 2004 for sedation of initially intubated and mechanically ventilated patients in the intensive care setting for use up to 24 hours. However, some ...
A study published in the June 2011 issue of the Annals of Pharmacotherapy indicates that increasing doses of the drug dexmedetomidine may not enhance sedation in critically ill patients, according to ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...
The α2-adrenergic agonist dexmedetomidine (DEX) is increasingly used for prolonged sedation of critically ill neonates, but there are currently no data evaluating possible consequences of prolonged ...
Interventional endoscopic procedures, such as endoscopic retrograde cholangiopancreatography (ERCP), often require sedation during the procedure. The most commonly used drugs for this purpose are ...
The researchers noted that while anesthesia induced with dexmedetomidine may more closely resemble natural sleep compared to other sedatives, which makes it particularly appropriate in procedures like ...
Alpha2-adrenergic receptor agonists didn't get critically ill patients off the ventilator quicker than propofol in the head-to-head A2B trial. Median time from randomization to successful extubation ...
Fresenius Kabi announced the launch of Dexmedetomidine Hydrochloride Injection, the generic version of Hospira‘s Precedex. Precedex is a selective alpha-2 adrenergic agonist. Approved by the FDA in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback